USD 1,650

Product Type

Industry Statistics

Release Date

14 January 2022

Region

Global

Release Year

2021

Table of Contents
    Add a header to begin generating the table of contents

    Description

    Arthritis refers to biomechanical changes within a joint. Osteoarthritis (OA) is the most common form of arthritis. It occurs most frequently in the hands, hips, and knees. A study by StrategyHelix indicates that the global osteoarthritis therapeutics market is expected to increase by US$ 3.36 billion from 2021 to 2027, garnering a CAGR of 6.7% during the forecast period.

    The report provides up-to-date market size data for period 2017-2020 and forecast to 2027 covering key market aspects like sales value for osteoarthritis therapeutics. The global osteoarthritis therapeutics market is segmented on the basis of anatomy, drug, drug classification, and region. Based on anatomy, the global osteoarthritis therapeutics market is categorized into knee osteoarthritis, hip osteoarthritis, and others. Globally, the knee osteoarthritis segment made up the largest share of the osteoarthritis therapeutics market. On the basis of drug, the global osteoarthritis therapeutics market has been segmented into viscosupplementation agents, non-steroidal anti-inflammatory drugs (NSAIDs), analgesics, and corticosteroids. By drug classification, the global osteoarthritis therapeutics market has been segmented into prescription drugs, and OTC. In terms of geography, the global osteoarthritis therapeutics market has been segmented into Asia Pacific, Europe, North America, and Rest of the World (RoW).

    The global osteoarthritis therapeutics market is highly competitive. Some of the leading companies operating in the market are Abbott Laboratories, Anika Therapeutics Inc., Bayer AG, Bioventus Inc., Eli Lilly and Company, Ferring B.V., Fidia Farmaceutici S.p.A., Flexion Therapeutics Inc., GlaxoSmithKline plc, Horizon Therapeutics plc, Johnson & Johnson, Novartis International AG, Pfizer Inc., Sanofi S.A., Seikagaku Corporation.

    The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the osteoarthritis therapeutics market to help drive informed decision making for industry executives, policy makers, academic, and analysts.


    Report Scope

    Anatomy: knee osteoarthritis, hip osteoarthritis, and others
    Drug: viscosupplementation agents, non-steroidal anti-inflammatory drugs (NSAIDs), analgesics, and corticosteroids
    Drug classification: prescription drugs, and OTC
    Region: Asia Pacific, Europe, North America, and Rest of the World (RoW)
    Years considered: this report covers the period 2017 to 2027


    Key Benefits for Stakeholders

    – Get a comprehensive picture of the global osteoarthritis therapeutics market
    – Pinpoint growth sectors and trends for investment


    Table of Contents

    1. Market definition
    2. Research methodology
    3. Market data and outlook
    3.1 Market size estimates
    3.2 Forecast
    4. Osteoarthritis therapeutics market by anatomy
    4.1 Knee osteoarthritis
    4.2 Hip osteoarthritis
    4.3 Others
    5. Osteoarthritis therapeutics market by drug
    5.1 Viscosupplementation agents
    5.2 Non-steroidal anti-inflammatory drugs (NSAIDs)
    5.3 Analgesics
    5.4 Corticosteroids
    6. Osteoarthritis therapeutics market by drug classification
    6.1 Prescription drugs
    6.2 OTC
    7. Osteoarthritis therapeutics market by region
    7.1 Asia Pacific
    7.2 Europe
    7.3 North America
    7.4 Rest of the World (RoW)
    8. Company profiles
    8.1 Abbott Laboratories
    8.2 Anika Therapeutics Inc.
    8.3 Bayer AG
    8.4 Bioventus Inc.
    8.5 Eli Lilly and Company
    8.6 Ferring B.V.
    8.7 Fidia Farmaceutici S.p.A.
    8.8 Flexion Therapeutics, Inc.
    8.9 GlaxoSmithKline plc
    8.10 Horizon Therapeutics plc
    8.11 Johnson & Johnson
    8.12 Novartis International AG
    8.13 Pfizer Inc.
    8.14 Sanofi S.A.
    8.15 Seikagaku Corporation
    9. Appendix
    9.1 About StrategyHelix
    9.2 Disclaimer


    StrategyHelix Black LOGO

    REQUEST SAMPLE

    Please fill out our form and we will get back to you.

    Global Osteoarthritis Therapeutics Market 2021

    StrategyHelix Black LOGO

    CUSTOM RESEARCH

    Custom projects can be researched to match your unique needs.

    Global Osteoarthritis Therapeutics Market 2021

    login